Mizuho's Top Stock Picks For November Revealed
Mizuho's Top Stock Picks For November Revealed
As trading for November begins, Mizuho recommends a few stocks for investors to consider. The Dow Jones, S&P 500, and Nasdaq Composite have all registered gains, marking a shift from October's downturn.
隨着11月交易的開始， 瑞穗市 推薦幾隻股票供投資者考慮。道瓊斯指數、標準普爾500指數和納斯達克綜合指數均上漲，這標誌着10月份的低迷有所轉變。
According to CNBC, Mizuho's equity research team has put together its top buy-rated picks for November. The list includes new names like Coterra Energy Inc (NYSE:CTRA), Merck & Co. (NYSE:MRK), EyePoint Pharmaceuticals (NASDAQ:EYPT) and Intuit (NASDAQ:INTU).
據CNBC報道，瑞穗的股票研究團隊已經彙總了11月份買入評級最高的精選。該列表包括新名字，例如 Coterra 能源公司 （紐約證券交易所：CTRA）， 默沙東公司 （紐約證券交易所：MRK）， EyePoint （納斯達克股票代碼：EYPT）和 Intuit （納斯達克股票代碼：INTU）。
Despite a Wall Street average rating of "hold" for Coterra, Mizuho is bullish on the stock, which is already up about 14% this year. Analyst Nitin Kumar points to the company's potential upside and its peer-leading cash return framework as reasons for optimism.
儘管華爾街對Coterra的平均評級爲 “持有”，但瑞穗仍看好該股，該股今年已經上漲了約14％。分析師尼廷·庫馬爾指出，該公司的潛在上行空間及其同行領先的現金回報框架令人樂觀。
See Also: Barron's Weekend Stock Picks: Chevron, Apple, Disney And Insulet's Stock Increase
另見：《巴倫週末》股票精選：雪佛龍、蘋果、迪士尼和Insulet的股票上漲
Mizuho is also positive about Merck, despite a nearly 7% dip in its stock this year. Analyst Mara Goldstein cites the company's promising pharmaceutical pipeline as a key growth driver.
儘管今年默沙東的股價下跌了近7％，但瑞穗也對默沙東持樂觀態度。分析師瑪拉·戈德斯坦指出，該公司前景廣闊的製藥產品線是關鍵的增長動力。
EyePoint Pharmaceuticals, whose shares have risen over 120% this year, is also on Mizuho's radar. Analyst Graig Suvannavejh highlights the company's focus on less frequently administered eye therapies as its unique selling point.
EyePoint Pharmicals的股價今年已上漲120％以上，也受到瑞穗的關注。分析師Graig Suvannavejh強調，該公司將重點放在使用頻率較低的眼科療法上，這是其獨特的賣點。
The last on the list, Intuit, is touted as a potential artificial-intelligence winner. Analyst Siti Panigrahi notes the company's defensible business model and its strong track record of growth.
名單上的最後一位Intuit被吹捧爲潛在的人工智能贏家。分析師西蒂·帕尼格拉希指出，該公司具有防禦能力的商業模式及其強勁的增長記錄。
The stocks of the four companies are anticipated to see further growth, with Mizuho's analysts offering optimistic projections for each.
預計這四家公司的股票將進一步增長，瑞穗的分析師對每家公司都給出了樂觀的預測。
The full list is below, along with the average rating via LSEG and the upside/downside to the average price target (%) via LSEG:
完整列表如下，以及倫敦證券交易所的平均評級以及倫敦證券交易所平均目標價（％）的上行/下行空間：
- Coterra Energy: Hold; 15.5
- Merck & Co: Buy; 20.9
- EyePoint Pharmaceuticals: Buy; 289.9
- Intuit: Buy, 13.5
- Mondelez International Inc (NASDAQ:MDLZ): Buy; 16.0
- DTE Energy Co (NYSE:DTE): Buy; 10.3
- Pentair PLC (NYSE:PNR): Buy; 20.4
- Omega Healthcare Investors Inc (NYSE:OHI): Hold; 8.1
- Amazon.com Inc (NASDAQ:AMZN): Buy; 24.4
- Nvidia Corp (NASDAQ:NVDA): Buy; 39.6
- 科特拉能源: 按住；15.5
- 默克公司: 購買；20.9
- EyePoint: 購買；289.9
- 直覺： 購買，13.5
- Mondelez 國際公司 （納斯達克股票代碼：MDLZ）：買入；16.0
- DTE 能源公司 （紐約證券交易所：DTE）： 購買；10.3
- Pentair PLC （紐約證券交易所代碼：PNR）：買入；20.4
- 歐米茄醫療投資公司 （紐約證券交易所代碼：OHI）：Hold；8.1
- 亞馬遜公司 （納斯達克股票代碼：AMZN）：買入；24.4
- 英偉達公司 （納斯達克股票代碼：NVDA）： 購買；39.6
Read Next: This Week In Apple: iPhone 16 Expectations, Wall Street's Overreaction On Q4 Guidance And More
繼續閱讀：本週蘋果報道：iPhone 16的預期、華爾街對第四季度指引的過度反應等等
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
該內容部分是在人工智能工具的幫助下製作的，並由Benzinga編輯審查和發佈。
Photo: Shutterstock
照片：Shutterstock